Wellington Management Group LLP Puma Biotechnology, Inc. Transaction History

Wellington Management Group LLP

  • $557 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$4.29 - $7.4 $732,581 - $1.26 Million
170,765 New
170,765 $905,000
Q4 2021

Feb 11, 2022
SELL
$2.85 - $6.58 $1.57 Million - $3.62 Million
-550,700 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$8.98 - $11.6 $216,220 - $279,304
-24,078 Reduced 4.19%
550,700 $5.06 Million
Q1 2021

May 17, 2021
BUY
$9.38 - $13.63 $529,707 - $769,713
56,472 Added 10.9%
574,778 $5.59 Million
Q4 2020

Feb 12, 2021
BUY
$7.78 - $12.13 $4.03 Million - $6.29 Million
518,306 New
518,306 $5.32 Million

Others Institutions Holding PBYI

# of Institutions
101
Shares Held
29M
Call Options Held
50.6K
Put Options Held
16.3K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $123M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email